Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
COVERING YOUR COMMUNITY. PEOPLE IN BOYNTON BEACH CAME TOGETHER YESTERDAY TO CELEBRATE A GOOD CAUSE. OUR MORNING ANCHOR TRAFFIC ANCHOR YASMINE JULMISSE EMCEED THE 2024 WALK TO DEFEAT ALS, CELEBRATING ...
The actor has a very personal project coming in 2026 with help from Maria Shriver.
McCormick played a key role passing Gov. Bill Haslam's Tennessee Promise bill, which offers two-year degrees tuition-free to every Tennessee student.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback